To elucidate the precise mechanisms by which SB225002 inhibits AF development, we examined the downstream signalling mediators of CXCR2, TGF‐β1 and Smad2/3, which are central mediators of fibrogenesis. The gene discussed is CXCR2; the disease is atrial fibrillation.